Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: J Pharm Pharmacol. 2012 Feb 21;64(5):727–734. doi: 10.1111/j.2042-7158.2012.01463.x

Fig. 3.

Fig. 3

Effects of irinotecan and panaxadiol on HCT-116 cell cycle. HCT-116 cells were treated with panaxadiol (10 μM) and/or irinotecan (1, 3, 5, 10 or 20 μM) for 48 h. Cell cycle profile was determined using flow cytometry after staining with PI/RNase. (a) Representative histograms of cell cycle distribution. (b) Percentage of each cell cycle phase with various treatments or with control. Data are presented as the mean ± SE of triplicate experiments.